Metabolism - Clinical and Experimental
Volume 59, Issue 8 , Pages 1092-1105, August 2010

Dietary fat intake promotes the development of hepatic steatosis independently from excess caloric consumption in a murine model

  • Vincent E. de Meijer

      Affiliations

    • Department of Surgery and the Vascular Biology Program, Children's Hospital Boston and Harvard Medical School, Boston, MA, USA
    • Department of Surgery, Erasmus MC–University Medical Center Rotterdam, the Netherlands
  • ,
  • Hau D. Le

      Affiliations

    • Department of Surgery and the Vascular Biology Program, Children's Hospital Boston and Harvard Medical School, Boston, MA, USA
  • ,
  • Jonathan A. Meisel

      Affiliations

    • Department of Surgery and the Vascular Biology Program, Children's Hospital Boston and Harvard Medical School, Boston, MA, USA
  • ,
  • M. Reza Akhavan Sharif

      Affiliations

    • Department of Radiology, Beth Israel Deaconess Medical Center, Boston, MA, USA
  • ,
  • Amy Pan

      Affiliations

    • Department of Surgery and the Vascular Biology Program, Children's Hospital Boston and Harvard Medical School, Boston, MA, USA
  • ,
  • Vânia Nosé

      Affiliations

    • Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA
  • ,
  • Mark Puder

      Affiliations

    • Department of Surgery and the Vascular Biology Program, Children's Hospital Boston and Harvard Medical School, Boston, MA, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 617 355 1838.

Received 29 April 2009; accepted 3 November 2009. published online 08 January 2010.

Abstract 

Nonalcoholic fatty liver disease results from overconsumption and is a significant and increasing cause of liver failure. The type of diet that is conducive to the development of this disease has not been established, and evidence-based treatment options are currently lacking. We hypothesized that the onset of hepatic steatosis is linked to the consumption of a diet with a high fat content, rather than related to excess caloric intake. In addition, we also hypothesized that fully manifested hepatic steatosis could be reversed by reducing the fat percentage in the diet of obese mice. C57BL/6J male mice were fed either a purified rodent diet containing 10% fat or a diet with 60% of calories derived from fat. A pair-feeding design was used to distinguish the effects of dietary fat content and caloric intake on dietary-induced hepatic lipid accumulation and associated injury. Livers were analyzed by quantitative reverse transcriptase polymerase chain reaction for lipid metabolism-related gene expression. After 9 weeks, mice on the 60%-fat diet exhibited more weight gain, insulin resistance, and hepatic steatosis compared with mice on a 10%-fat diet with equal caloric intake. Furthermore, mice with established metabolic syndrome at 9 weeks showed reversal of hepatic steatosis, insulin resistance, and obesity when switched to a 10%-fat diet for an additional 9 weeks, independent of caloric intake. Quantitative reverse transcriptase polymerase chain reaction revealed that transcripts related to both de novo lipogenesis and increased uptake of free fatty acids were significantly up-regulated in mice pair-fed a 60%-fat diet compared with 10%-fat–fed animals. Dietary fat content, independent from caloric intake, is a crucial factor in the development of hepatic steatosis, obesity, and insulin resistance in the C57BL/6J diet-induced obesity model caused by increased uptake of free fatty acids and de novo lipogenesis. In addition, once established, all these features of the metabolic syndrome can be successfully reversed after switching obese mice to a diet low in fat. Low-fat diets deserve attention in the investigation of a potential treatment of patients with nonalcoholic fatty liver disease.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Institutional approval: Animal protocols complied with the National Institutes of Health Animal Research Advisory Committee guidelines and were approved by the Children's Hospital Boston Animal Care and Use Committee (protocol no. A06-08-065R).

PII: S0026-0495(09)00476-4

doi:10.1016/j.metabol.2009.11.006

Metabolism - Clinical and Experimental
Volume 59, Issue 8 , Pages 1092-1105, August 2010